CSPC Pharmaceutical Group Limited (1093.HK)
HKD 4.79
(0.84%)
HKD 4.79
(0.84%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.92 Billion | 9.22 Billion | 5.86 Billion | 7.67 Billion | 4.39 Billion | 3.88 Billion |
| Net Income | 6.49 Billion | 7.08 Billion | 6.75 Billion | 5.79 Billion | 4.21 Billion | 3.95 Billion |
| Depreciation & Amortization | 1.23 Billion | 1.21 Billion | 1.04 Billion | 906.91 Million | 784.21 Million | 655.25 Million |
| Deferred income taxes | - | -2.72 Billion | -4.82 Billion | -818.8 Million | - | - |
| Stock-based compensation | 235.09 Million | 160.72 Million | 17.73 Million | 9.12 Million | - | - |
| Change in working capital | -3.03 Billion | 928.11 Million | -1.67 Billion | 1.88 Billion | -549.73 Million | 179.36 Million |
| Other non-cash items | -334.59 Million | 2.56 Billion | 4.54 Billion | -108.69 Million | 2.61 Billion | -899 Million |
| Investing Cash Flow | 924.12 Million | -8.18 Billion | -1.05 Billion | -2.59 Billion | -2.87 Billion | -3.7 Billion |
| Investments in PPE | -2.09 Billion | -3.16 Billion | -2.11 Billion | -1.76 Billion | -2.4 Billion | -2.17 Billion |
| Acquisitions | -115 Million | -331.94 Million | 285.15 Million | -307.42 Million | -537.33 Million | -155.93 Million |
| Investment purchases | -4.72 Billion | -8.71 Billion | -6.51 Billion | -5.16 Billion | -3 Billion | -3.86 Billion |
| Sales/Maturities of investments | 6.74 Billion | 3.97 Billion | 7.27 Billion | 4.66 Billion | 3.09 Billion | 68.81 Million |
| Other Investing Activities | 167.56 Million | 48.61 Million | 15.58 Million | -20.37 Million | -14.68 Million | 2.41 Billion |
| Financing Cash Flow | -3.16 Billion | -2.22 Billion | -2.64 Billion | -1.65 Billion | -1.76 Billion | -157.32 Million |
| Debt repayment | -30.76 Million | -11.62 Million | -119.31 Million | -189.9 Million | -53.96 Million | -827 Million |
| Dividends payments | -3.01 Billion | -2.43 Billion | -2.03 Billion | -1.71 Billion | -1.09 Billion | -936.45 Million |
| Common Stock Repurchased | -200.35 Million | -16.52 Million | -317.58 Million | -0.48 | -114.19 Million | -86.81 Million |
| Common Stock Issuance | - | -161.27 Million | -157 Million | -115.33 Million | 1.29 Billion | - |
| Other Financing Activities | 557.95 Million | 404.97 Million | -15.06 Million | 371.12 Million | -1.72 Billion | 1.57 Billion |
| Accounts receivables | -3.63 Billion | -525.29 Million | -2.31 Billion | -51.14 Million | -1.1 Billion | -688.19 Million |
| Accounts payables | 918.99 Million | 441.04 Million | 333.59 Million | 379.47 Million | -580.41 Million | 547.11 Million |
| Inventory | -583.74 Million | -49.71 Million | -743.69 Million | 675.82 Million | 577.52 Million | -638.95 Million |
| Other working capital | 13.94 Million | 1.06 Billion | 1.05 Billion | 883.84 Million | 553.28 Million | 959.4 Million |
| Cash at beginning of period | 11.56 Billion | 11.35 Billion | 8.65 Billion | 4.81 Billion | 4.93 Billion | 4.53 Billion |
| Cash at end of period | 13.22 Billion | 11.56 Billion | 11.35 Billion | 8.65 Billion | 4.81 Billion | 4.32 Billion |
| Capital Expenditure | -2.09 Billion | -3.16 Billion | -2.11 Billion | -1.76 Billion | -2.4 Billion | -2.17 Billion |
| Effect of forex changes on cash | 4.89 Million | 14.13 Million | -2.44 Million | 2.1 Million | 133.02 Million | -234.34 Million |
| Net cash flow / Change in cash | 1.66 Billion | 205.62 Million | 2.7 Billion | 3.83 Billion | -115.11 Million | -207.72 Million |
| Free Cash Flow | 2.83 Billion | 6.05 Billion | 3.74 Billion | 5.9 Billion | 1.98 Billion | 1.71 Billion |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.24 Billion | 3.19 Billion | 6.49 Billion | 3.35 Billion | 7.08 Billion | 3.5 Billion |
| Depreciation & Amortization | 678.59 Million | 644.22 Million | 1.23 Billion | 599.68 Million | 1.21 Billion | 634.01 Million |
| Deferred income taxes | - | - | - | - | -2.72 Billion | - |
| Stock-based compensation | 127.04 Million | 138.12 Million | 235.09 Million | - | 160.72 Million | - |
| Change in working capital | - | -4.04 Billion | -3.03 Billion | - | 928.11 Million | 895.55 Million |
| Other non-cash items | -2.51 Billion | 3.2 Billion | -334.59 Million | -1.12 Billion | 2.56 Billion | -277.09 Million |
| Investing Cash Flow | -2.29 Billion | -267.85 Million | 924.12 Million | 1.23 Billion | -8.18 Billion | -763.6 Million |
| Investments in PPE | -697.58 Million | -983.05 Million | -2.09 Billion | -1.15 Billion | -3.16 Billion | -1.88 Billion |
| Acquisitions | - | -17.51 Million | -115 Million | 496.21 Million | -331.94 Million | -32.02 Million |
| Investment purchases | - | -442.52 Million | -4.72 Billion | -4.5 Billion | -8.71 Billion | -1.72 Billion |
| Sales/Maturities of investments | - | 647.85 Million | 6.74 Billion | 6.64 Billion | 3.97 Billion | 2.83 Billion |
| Other Investing Activities | -1.59 Billion | 715.19 Million | 167.56 Million | -240.48 Million | 48.61 Million | 46.9 Million |
| Financing Cash Flow | -2.45 Billion | -1.37 Billion | -3.16 Billion | -1.6 Billion | -2.22 Billion | -1.21 Billion |
| Debt repayment | -85.92 Million | -24.3 Million | -30.76 Million | -39.15 Million | -11.62 Million | -433.34 Million |
| Dividends payments | -1.64 Billion | -1.67 Billion | -3.01 Billion | -1.36 Billion | -2.43 Billion | -1.12 Billion |
| Common Stock Repurchased | -379.48 Million | -269.22 Million | -200.35 Million | -226.59 Million | -16.52 Million | 1.21 Million |
| Common Stock Issuance | - | -66.93 Million | - | 66.93 Million | -161.27 Million | -77.49 Million |
| Other Financing Activities | -347.83 Million | 296.69 Million | 557.95 Million | -29.4 Million | 404.97 Million | 415.48 Million |
| Accounts receivables | - | -2.17 Billion | -3.63 Billion | - | -525.29 Million | - |
| Accounts payables | - | - | 918.99 Million | - | 441.04 Million | - |
| Inventory | - | -642.19 Million | -583.74 Million | - | -49.71 Million | - |
| Other working capital | - | -1.22 Billion | 13.94 Million | - | 1.06 Billion | - |
| Cash at beginning of period | 11.27 Billion | 9.86 Billion | 11.56 Billion | 11.56 Billion | 11.35 Billion | 10.62 Billion |
| Cash at end of period | 8.05 Billion | 11.57 Billion | 13.22 Billion | 11.29 Billion | 11.56 Billion | 11.56 Billion |
| Capital Expenditure | -697.58 Million | -983.05 Million | -2.09 Billion | -1.15 Billion | -3.16 Billion | -1.88 Billion |
| Effect of forex changes on cash | 1.31 Million | -1.14 Million | 4.89 Million | -1.54 Billion | 14.13 Million | -574.06 Million |
| Net cash flow / Change in cash | -3.21 Billion | 1.71 Billion | 1.66 Billion | -271.84 Million | 205.62 Million | 937.05 Million |
| Free Cash Flow | 834.07 Million | 2.16 Billion | 2.83 Billion | 473.8 Million | 6.05 Billion | 1.6 Billion |
3544
SVNDF
0640
009440
SDMU
KOPI